NBIX vs MSFT: Which Stock is Better?
Side-by-side comparison of Neurocrine Biosciences Inc and Microsoft Corporation in 2026
NBIX
Neurocrine Biosciences Inc
$153.88
MSFT
Microsoft Corporation
$510.89
Key Metrics Comparison
| Metric | NBIX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $13.21B | $3.71T | MSFT |
| P/E Ratio | 31.57 | 33.89 | NBIX |
| EPS (TTM) | $4.19 | $14.08 | MSFT |
| Revenue Growth | 27.8% | 18.4% | NBIX |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze NBIX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is NBIX or MSFT a better investment?
Comparing NBIX and MSFT: Neurocrine Biosciences Inc has a market cap of $13.21B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between NBIX and MSFT?
NBIX (Neurocrine Biosciences Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: NBIX or MSFT?
Based on P/E ratios, NBIX trades at a lower multiple (31.6x vs 33.9x).
Which is growing faster: NBIX or MSFT?
NBIX has higher revenue growth at 27.8% vs 18.4% for MSFT.
Which company is more profitable: NBIX or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for NBIX.
Which is the larger company: NBIX or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $13.21B for NBIX.
Should I buy NBIX or MSFT in 2026?
Both NBIX and MSFT have investment merit. NBIX trades at $153.88 while MSFT trades at $510.89. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between NBIX and MSFT stock?
Key differences: Market Cap ($13.21B vs $3.71T), P/E Ratio (31.6x vs 33.9x), Revenue Growth (27.8% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy NBIX or MSFT in 2026?
The choice between NBIX and MSFT depends on your investment goals. NBIX shows higher revenue growth (27.8%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between NBIX and MSFT?
NBIX (Neurocrine Biosciences Inc) has a market cap of $13.21B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.